DB
SER icon

Danske Bank’s Serina Therapeutics SER Stock Holding History

Danske Bank’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$13 – 1676
2024
Q3 		$13 Buy
+2
New +$16 ﹤0.01% 1521

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Danske Bank's SER Position: Q4 2024 in Review

Danske Bank sold out of Serina Therapeutics (SER) in Q4 2024, closing a stake of 2 shares — an estimated $13 sold.

Danske Bank first reported a position in SER in Q3 2024 and held it in 1 quarter. The position peaked at $13 in Q3 2024. 25 funds tracked by Wall St. Rank hold SER as of Q4 2024.

  • Danske Bank reported no remaining Serina Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Danske Bank sold 2 Serina Therapeutics shares in Q4 2024, an estimated $13.
  • Danske Bank first reported a position in Serina Therapeutics in Q3 2024 and held it in 1 quarter.
  • Danske Bank's Serina Therapeutics position peaked at $13 in Q3 2024.
  • 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.